FNF heads into Wednesday's Q2 results with options traders breaking sharply from their recent defensive posture — a notable contrast to a short-selling picture that remains calm.
The most striking signal comes from the options market. Positioning has turned unusually bullish relative to recent history: the put/call ratio dropped to 0.83 on July 31, nearly 2.5 standard deviations below its 20-day average of 1.19. For most of June and early July, the PCR ran well above 1.0 — at times reaching 4-5 — reflecting heavy demand for downside protection. That hedging has been rapidly unwound, leaving the current reading as one of the most call-skewed in the past year. The stock itself has recovered 9.4% over the past month to $51.59, despite slipping fractionally on the week.
Short interest tells a straightforward, low-pressure story. Bears hold roughly 3.5% of the free float — a modest position that has edged down about 1.8% over the past week, after climbing 10.7% over the prior month. Borrow conditions are essentially frictionless: availability runs at more than 4,500% of shares short, meaning the lending pool is nowhere near tapped, and the cost to borrow, while up 67% week-on-week, remains negligible at 0.50%. There is no meaningful squeeze pressure building here.
The bull-bear debate for FNF centres on two businesses pulling in opposite directions. Bulls point to the F&G annuity segment, which posted 47% year-on-year gross sales growth to $4.4 billion last quarter, with assets under management climbing 13% to $52.2 billion — a clear bright spot. Bears focus on the Title segment, where earnings fell 38% year-on-year and pretax margins dropped well below management's stated 20% target, with a sluggish housing market and elevated mortgage rates offering little near-term relief. The mean analyst price target is $61.40 — roughly 19% above the current price — though most recent moves have been target reductions: Barclays nudged its Equal-Weight target up marginally to $51 in early July, while KBW trimmed its Outperform target to $64 from $67 in late June, and Stephens cut to $58 earlier in the spring. The direction of travel from the Street has been cautiously lower even as ratings hold.
The earnings report will test whether the F&G growth engine can keep expanding fast enough to offset a Title business that has yet to find a floor, and whether management's margin recovery narrative carries enough conviction to close the gap between the stock price and a consensus target that the Street has been steadily marking down.
See the live data behind this article on ORTEX.
Open FNF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
